Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence / Wednesday, March 5, 2025 / Article rating: 5.0 The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share.
Big Pharma's Latest Move: Acquisition Unlocks $15 Million Market Opportunity in the U.S.! Big Pharma's Latest Move: Acquisition Unlocks $15 Million Market Opportunity in the U.S.! Pharma Company Expands Injectable Portfolio with New Launch Targeting U.S. Hospital Market DSIJ Intelligence / Monday, March 3, 2025 / Article rating: 5.0 Pharma Company Expands Injectable Portfolio with New Launch Targeting U.S. Hospital Market
Pharma Major-Sanofi India Reports 8 Per Cent Growth in Q4 2024 Net Sales Amid Strategic Demerger Pharma Major-Sanofi India Reports 8 Per Cent Growth in Q4 2024 Net Sales Amid Strategic Demerger Total revenue from operations for the full year 2024 was Rs 2,013.2 crore, showing a slight increase from Rs 1,996.1 crore in 2023. DSIJ Intelligence / Friday, February 28, 2025 / Article rating: 5.0 The company has maintained a final dividend of Rs 117 per equity share, subject to shareholder approval.
Pharma penny stock under Rs 35 in green after acquiring 10,000 shares of its Singapore subsidiary Pharma penny stock under Rs 35 in green after acquiring 10,000 shares of its Singapore subsidiary The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share. DSIJ Intelligence / Thursday, February 27, 2025 / Article rating: 4.0 The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share.
Pharma Stock to Watch! FIIs & DIIs Bet Big as This Drugmaker Launches a New Eye Treatment in the US! Pharma Stock to Watch! FIIs & DIIs Bet Big as This Drugmaker Launches a New Eye Treatment in the US! FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market! DSIJ Intelligence / Friday, February 14, 2025 / Article rating: 3.3 FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market!
114 Per Cent Returns: Multibagger Pharma Company Reports 81 Per Cent PAT Growth; Sales Up 9 Per Cent 114 Per Cent Returns: Multibagger Pharma Company Reports 81 Per Cent PAT Growth; Sales Up 9 Per Cent The company's net profit surged 81 per cent year-on-year (YoY) to Rs 276.4 crore, compared to Rs 152.9 crore in Q3 FY24. DSIJ Intelligence / Thursday, February 13, 2025 / Article rating: 3.8 Revenue grew by 9 per cent YoY to Rs 2,245.4 crore, up from Rs 2,052.9 crore in the corresponding quarter last year.
Pharma Major Shares Rebound from Lows; Firm Reports 39.5 per cent Profit Growth Pharma Major Shares Rebound from Lows; Firm Reports 39.5 per cent Profit Growth The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24 DSIJ Intelligence / Wednesday, February 12, 2025 / Article rating: 5.0 The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24
Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25 Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25 From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent. DSIJ Intelligence / Tuesday, January 28, 2025 / Article rating: 4.2 From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent.
This Pharma Stock Declines 4.86 per cent; Board Approves Rs 570 Crore Fundraise, Know the Stock Outlook Here This Pharma Stock Declines 4.86 per cent; Board Approves Rs 570 Crore Fundraise, Know the Stock Outlook Here The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis DSIJ Intelligence / Monday, January 27, 2025 / Article rating: 3.3 The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis
33 Per Cent Jump In PAT: Pharma Penny Stock Under Rs 60 Jumps Over 5 Per Cent On January 23 33 Per Cent Jump In PAT: Pharma Penny Stock Under Rs 60 Jumps Over 5 Per Cent On January 23 From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent. DSIJ Intelligence / Thursday, January 23, 2025 / Article rating: 4.6 From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent.